Surfactant Protein D Enhances Phagocytosis and Killing of Unencapsulated Phase Variants of Klebsiella pneumoniae

I Ofek, A Mesika, M Kalina, Y Keisari… - Infection and …, 2001 - Am Soc Microbiol
I Ofek, A Mesika, M Kalina, Y Keisari, R Podschun, H Sahly, D Chang, D McGregor…
Infection and immunity, 2001Am Soc Microbiol
Pulmonary surfactant protein D (SP-D) is a collagenous C-type lectin (collectin) that is
secreted into the alveoli and distal airways of the lung. We have studied the interactions of
SP-D and alveolar macrophages with Klebsiella pneumoniae, a common cause of
nosocomial pneumonia. SP-D does not agglutinate encapsulated K. pneumoniae but
selectively agglutinates spontaneous, unencapsulated phase variants, such as Klebsiella
strain K50-3OF, through interactions with their lipopolysaccharides (LPS). These effects are …
Abstract
Pulmonary surfactant protein D (SP-D) is a collagenous C-type lectin (collectin) that is secreted into the alveoli and distal airways of the lung. We have studied the interactions of SP-D and alveolar macrophages with Klebsiella pneumoniae, a common cause of nosocomial pneumonia. SP-D does not agglutinate encapsulated K. pneumoniae but selectively agglutinates spontaneous, unencapsulated phase variants, such as Klebsiella strain K50-3OF, through interactions with their lipopolysaccharides (LPS). These effects are calcium dependent and inhibited with maltose but not lactose, consistent with involvement of the SP-D carbohydrate recognition domain. Precoating of K50-3OF with SP-D enhances the phagocytosis and killing of these organisms by rat alveolar macrophages in cell culture and stimulates the production of nitric oxide by the NR-8383 rat alveolar macrophage cell line. SP-D similarly enhances the NO response to K50-3OF LPS adsorbed to Latex beads under conditions where soluble LPS or SP-D, or soluble complexes of SP-D and LPS, do not stimulate NO production. Our studies demonstrate that interactions of SP-D with exposed arrays of Klebsiella LPS on a particulate surface can enhance the host defense activities of alveolar macrophages and suggest that activation of macrophages by SP-D requires binding to microorganisms or other particulate ligands. Because unencapsulated phase variants are likely to be responsible for the initial stages of tissue invasion and infection, we speculate that SP-D-mediated agglutination and/or opsonization of K. pneumoniae is an important defense mechanism for this respiratory pathogen in otherwise healthy individuals.
American Society for Microbiology